Navigation Links
AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007
Date:2/28/2008

es

Repurchase of common stock (803) (15,168)

Exercise of stock options and warrants 413 1,632

Tax benefit from change in valuation allow related

to stock option exercises - 443

Cash (used in) provided by financing activities (390) (13,093)

Increase (decrease) in cash and cash equivalents 1,205 (74,883)

Cash and cash equivalents at beginning of year 7,331 82,214

Cash and cash equivalents at end of year $8,536 $7,331

Supplemental disclosure of cash paid during the

period for:

Income taxes, net of refunds $91 $2,425

Non-cash investing activities:

Unrealized gain (loss) on available-for-sale securities $64 $(4)

2008 Projected

Reconciliation of projected net loss to projected Lower Upper

EBITDA Range Range

Projected net loss $(1,350) $(850)

Interest income 3,000 3,000

Operating loss (4,350) (3,850)

Non-cash stock compensation expense 1,816 1,816

Depreciation and amortization 1,286 1,286

Amortization of software development costs 2,286 2,286

Projected EBITDA 1,037 1,537


'/>"/>
SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call
2. AMICAS to Present at UBS Global Healthcare Services Conference
3. MedQuest Standardizes on AMICAS Vision Series PACS
4. AMICAS Solutions Closing the Loop in Radiology Communications
5. AMICAS Transforms Critical Results Notification with RadStream
6. AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow
7. Webcast Alert: AMICAS, Inc. Announces 3rd Quarter 2007 Earnings Conference Call
8. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
9. AMICAS Schedules Third Quarter Earnings Call
10. AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference
11. AMICAS Hosts Complimentary DRA Education Session Featuring Timothy Trysla
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...swire-USNewswire/ -- The American Heart,Associatio... Lewis,Achievement Award, the association,s highes...ard was established in 2000, to recognize and hono...edical journalists who have documented,the conside...ease and,stroke. This career achievement award was...
(Date:7/23/2008)...23 /PRNewswire-USNewswire/ -- The Alameda County,P...ly 24-26 at the Oakland,Marriott to address the so...in individuals from low-income and communities of ...s and counties will attend. Place Matters,is a nat... and Economic,Studies, Health Policy Institute and...
(Date:7/23/2008)...e Dangerous for Morbidly Obese Women? ,As the ...are consulting plastic surgeons for breast reducti...ad been thought to have higher complication rates....e as safe to perform large-volume breast reduction...Study title: Breast Reduction: Safe in the Morbidl...
(Date:7/23/2008)...23 /PRNewswire-USNewswire/ -- The New Jersey,Hospi...t Safety has,received a planning grant for $199,50...o develop a proposal for improving the quality of,...termine over the next six months whether New,Jerse... Quality initiative,which is focused on lifting t...
Breaking Medicine News(10 mins):Health News:Alameda County Hosts National Initiative to Reduce Health Disparities 2
...came to an abrupt end when a guest discovered bodi... Didier Charrons wife Chantal, 46, and son Bryan ...lping to clear up after a dinner with a group of f...s home in the city of Verviers, 78 miles east of B...
...tion today announced that with the initiation of a...n in Los Angeles, it will accelerate the recruitm...linical study of EPC2407, a novel small molecule v...cer for the treatment of patients with advanced so...
...ies on Thursday reported 38 new cases of the feare... the country's east . The regional authorities in...8 dead birds found on the shores of an artificial ...elbra had all tested positive. Saxony-Anhalt is t...
...ood massage, a bath under a medicinal waterfall, f...f by a good sleep at a comfortable resting place,...certified to have curative qualities by thousands ...tralam regularly. The water that comes down from ...
Other Medicine News:Health News:Dinner Guest Recover Bodies in Freezer 2Health News:EpiCept Accelerates Development of Phase I Clinical Study for Cancer 2
(Date:7/23/2008)...SEATTLE, July 23 /- Sound Pharmaceuti...pplication with the FDA for the clinical,testing o...vention of,chemotherapy induced hearing loss or ot...I-3005, will be tested in advanced stage lung canc...tinum based chemotherapy.,This marks the second de...
(Date:7/23/2008)...SAN FRANCISCO, July 23 /- InCode BioP...company, today announced preclinical test,results ...date rC3-1 for,the treatment of the rare chronic b...(PNH). The complete results will be presented at t..., Switzerland, September 28,2008., The only trea...
(Date:7/22/2008)...- Strong efficacy results from a multi-center 293-...com , Toronto Stock Exchange Symbol: CYT, MONTRE...echnologies,Inc., the global leader in cryotherapy...unced that results previously presented from three...roduct, Arctic Front(R),were published earlier to...
(Date:7/22/2008)...tudy Demonstrates Feasibility and Efficacy of Trea...y Liver Cancer, SAN FRANCISCO, and YONGIN-SI, Sou...San Francisco, CA and Ottawa, Ontario), and its So...day that novel findings from,a Phase I clinical tr...nstrated that the product was well-tolerated and r...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4U S Army Selects Cogon Systems to Develop Advanced Clinical Decision Support Tools for Hand Held Computers 5170 1U S Army Selects Cogon Systems to Develop Advanced Clinical Decision Support Tools for Hand Held Computers 5170 2Announcing Always Best Care Senior Services Expansion Into the Littleton Denver Colorado Area 5167 1Announcing Always Best Care Senior Services Expansion Into the Littleton Denver Colorado Area 5167 2Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 1Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 2Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 3Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 4Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 5Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 6Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 7Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 8Align Technology Inc Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific 26 Medical Equipment and Bio Technology Com 1624 1Align Technology Inc Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific 26 Medical Equipment and Bio Technology Com 1624 2Align Technology Inc Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific 26 Medical Equipment and Bio Technology Com 1624 3
...(BUSINESS WIRE)--Jul 2, 2007 - Ceragenix Pharmaceu...pany focused on,infectious disease and dermatology...ty of Pennsylvania led by Dr. Paul,Janmey and Dr. ...vage of Brigham Young University, have demonstrate...stigational drug compound known,as CSA-13 shows pr...
...TON, January 29, 2007 /PRNewswire-USNewswire/ -- R...he President,s,Malaria Coordinator, announced his ...ty Coordinator of the President,s Malaria,Initiati...the U.S.,Public Heath Service and has most recentl...ion, at the Global Fund to Fight,AIDS, Tuberculosi...
Other Medicine Technology:Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 2Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 3Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 4Studies of Drug Resistance May Lead to Individual Therapy for Rare,Cancers 2
BD Vacutainer® Fluoride Tubes - Glass
BD Vacutainer® Specialty Tubes - Trace Element - Glass
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients.
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology.
Medicine Products: